Surfactin-Triggered Small Vesicle Formation of Negatively Charged Membranes: A Novel Membrane-Lysis Mechanism  by Buchoux, Sébastien et al.
Surfactin-Triggered Small Vesicle Formation of Negatively Charged
Membranes: A Novel Membrane-Lysis Mechanism
Se´bastien Buchoux,* Jose´phine Lai-Kee-Him,* Marie Garnier,* Pascale Tsan,§ Francxoise Besson,y
Alain Brisson,* and Erick J. Dufourc*
*UMR 5248 CBMN, CNRS–Universite´ Bordeaux 1, ENITAB, IECB, Pessac, France; §UMR 5078 CNRS–Universite´ C. Bernard Lyon 1, Lyon,
France; and yUMR 5246 ICBMS, CNRS–Universite´ C. Bernard Lyon 1, Lyon, France
ABSTRACT Themolecularmode of action of the lipopeptide SFwith zwitterionic and negatively chargedmodel membranes has
been investigated with solid-state NMR, light scattering, and electron microscopy. It has been found that this acidic lipopeptide
(negatively charged) induces a strong destabilization of negatively charged micrometer-scale liposomes, leading to the formation
of small unilamellar vesicles of a few 10s of nanometers. This transformation is detected for very low doses of SF (Ri¼ 200) and is
complete for Ri ¼ 50. The phenomenon has been observed for several membrane mixtures containing phosphatidylglycerol or
phosphatidylserine. The vesicularization is not observed when the lipid negative charges are neutralized and a cholesterol-like
effect is then evidenced, i.e., increase of gel membrane dynamics and decrease of ﬂuid membrane microﬂuidity. The mechanism
for small vesicle formation thus appears to be linked to severe changes in membrane curvature and could be described by a two-
step action: 1), peptide insertion into membranes because of favorable van der Waals forces between the rather rigid cyclic and
lipophilic part of SF and lipid chains and 2), electrostatic repulsion between like charges borne by lipid headgroups and the
negatively charged SF amino acids. This might provide the basis for a novel mode of action of negatively charged lipopeptides.
INTRODUCTION
Membrane-lytic peptides are known to be used for both of-
fensive (in venoms, for instance) and defensive purposes.
They play a major role in the invertebrate class and have been
isolated from a wide range of organisms (from insects (1) to
humans (2)). Most of these peptides exhibit antimicrobial
activity and are composed of relatively small linear poly-
peptides (,40 amino acids) structured in a-helix (mainly),
b-sheet, or cystein-stabilized a-helix-b-sheet folds. They
have been intensively studied to understand how they interact
with lipid membranes. Two main mechanisms of induced
membrane destabilization have emerged from literature:
‘‘carpet’’ (3) and ‘‘barrel’’ (4) models, both requiring a helix
conformation of the lytic peptide and leading to detergent-
like action or pore formation. On the other hand, lipopeptides
constitute a relatively new interest in the antimicrobial pep-
tides family. The main difference between lipopeptides and
more classical lytic peptides is the presence of a carbonated
chain in complement to the peptidic backbone. Most de-
scribed peptides (mainly from Bacillus species), include
polymyxin (5), iturin (6), fengycin (7), and SF (8). SF is
secreted by Bacillus subtilis and was discovered in the late
1960s (8). It was named after its ability to lower water surface
tension from 72 mN/m to 27 mN/m (9). The morphology of
SF is quite unusual because it is composed of a ring-shaped
peptidic backbone of seven amino acids in a chiral sequence
of L/D enantiomers: LLDLLDL. The ring is closed by a
b-hydroxy fatty acid with different aliphatic chains (Fig. 1)
(9). The amino acid sequence of the peptidic ring may differ
according to genetic methods and/or strand used for bio-
synthesis (10), but in all cases it is composed of ﬁve lipophilic
amino acids and two negatively charged hydrophilic ones
(glutamic and aspartic acids) (8,11). Depending on the
strand, the length of the hydrocarbon chain may also vary
from 12 to 14 carbon atoms. Because of the presence of both
a lipophilic and a hydrophilic part, SF exhibits powerful
surfactant capabilities such as emulsiﬁcation and foaming
(8,12). SF also has interesting biological properties: it in-
hibits ﬁbrin clot formation (8,13) and is quite an efﬁcient
antibacterial (14), antimycoplasmic (15), antitumoral (16–
18), antiviral (19), and hypocholesterolemic (20) agent.
Given these properties, SF has been proposed to be used to
ensure safety of pharmaceutical products (15,21). Despite
this impressive array of activities, only a few structural
studies have been made: the structure of SF in dimethyl-
sulfoxide solution or in detergent micelles is known (22,23)
and has given a few clues on the mechanisms of interactions
between SF and its multiple targets, but no major issue has
risen concerning the minute mechanism for interactions. In
particular, its mode of action toward biological membranes is
still poorly understood. Computational studies and com-
pression isotherms on a Langmuir trough have proposed that
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SF may form clusters of seven monomers when interacting
at the air/water interface (24), and a detergent-like effect
on zwitterionic lipid model membranes has been reported
from calorimetric studies at very elevated doses of SF (25–
27), but interactions between SF and charged lipid membranes
(such as Mycoplasma membranes) are still unknown.
Our purpose was to better understand the interaction
mechanism by which SF induces the lysis of natural mem-
branes. In this work, solid-state deuterium and phosphorus-
31 NMR (2H-NMR, 31P-NMR), DLS, and TEM have been
used to study the effect of SF against model membranes
mimicking microorganism plasma membranes. In particular,
three different systems have been investigated: DMPG/SM
mixture (1:1 molar ratio), DMPC/DMPG mixture (1:1 molar
ratio), and DMPC/DMPS mixture (1:1 molar ratio). These
systems provide a good variety in lipid dynamics (SM is well
known to be involved with cholesterol in rigid domain for-
mation (28,29) as well as in lipid headgroup charge (PC and
SM are both zwitterionic, whereas PG is anionic). PS is an
interesting lipid because it is zwitterionic below pH 5 and
negatively charged at pH 7. A DMPG/SM system may also
be representative of Mycoplasmas lipid membrane compo-
sition (30) and so can be used to study biological properties of
SF on a simpliﬁed model. Pure DMPC bilayers have been
also used as a zwitterionnic model membrane. To enable 2H
NMR spectroscopy, lipids were (partially) deuterium labeled.
When necessary, lipid structural and dynamic properties were
determined by calculation of spectral moments and of SCD.
MATERIALS AND METHODS
Chemicals
Brain SM, DMPG, DMPS, DMPC, DMPC-2H27, and DMPG-
2H27 were
purchased from Avanti Polar Lipids (Birmingham, AL) and used without
further puriﬁcation. SF (1GluLeuLeuValAspLeuLeu7-isoC14, MW ¼
1036.34; Fig. 1) and other reagents were purchased from Sigma-Aldrich (St.
Louis, MO). SF was checked for purity by mass spectrometry. Deuterium-
depleted water was obtained from Eurisotop (Saint Aubin, France).
Multilamellar vesicle preparation
Except for the DMPC-2H27 system, all lipid systems were ﬁrst dissolved in
an organic solvent (chloroform) to achieve complete mixing of lipids. The
organic solvent was then evaporated, and lipids were dried under high-
vacuum pumping during several hours. To remove residual chloroform, the
sample was hydrated with a large excess of water and highly vortex mixed
before being freeze-dried. Finally, a 50 mM Tris-HCl buffer solution was
added to lipids to reach 90% hydration (mass water/total mass) for NMR ex-
periments (;350 mM). Formation of homogeneous multilamellar vesicles
wass achieved with three to four freeze-thaw-mixing cycles: after being frozen
in liquid nitrogen, sample was incubated for 10 min at 50C (i.e., well above
the ‘‘gel-ﬂuid’’ transition temperature of all systems) and vortex mixed.
Sample was then transferred into a 4-mm (;80 mL) NMR rotor for wide line
experiments. For DLS, it was diluted 100 times and transferred into a 5-mm-
diameter tube (250 mL, 3.5 mM). In the case of TEM experiments, an addi-
tional dilutionwas performed to reach a concentration of 1mM; a 5-mLvolume
was then deposited on the carbon-coated copper grid. For SF-containing sys-
tems, SF powder was added to lipids before sample dissolution in chloroform;
SF and lipids were then homogeneously mixed through dissolution in organic
solvent. Sample preparation as described above was then applied. SF/lipid
molar ratios of 25, 30, 50, 100, and 200 were prepared. Complementary ex-
perimentswere also performedwith external addition of SF as a buffermicellar
solution (millimolar concentrations, i.e., well above the critical micelle con-
centration, which is a few micromolar) to already-prepared lipid solution.
Equilibrium was also ensured using several freeze-thaw-vortex mixing cycles.
NMR spectroscopy
NMR experiments were carried out on Bruker Avance (Wissembourg,
France) DSX 500 WB US (11.75 T) operating at 76.8 MHz for 2H-NMR,
DPX 400 NB US (9.4 T) operating at 161.9 MHz for 31P-NMR, and DSX
300 WB US (7.05 T) operating at 46.1 MHz for 2H-NMR. Pulse sequences
used are a classical quadrupolar solid echo 90x-t-90y-t-acq (31) for 2H-
NMR and a Hahn-echo proton-decoupled for 31P-NMR (32,33). Interpulse
delays, t, ranged from 30ms at 11.75 T and 9.4 T to 50ms at 7.05 T. A recycle
delay of 1.5 s was used on both spectrometers for 2H-NMR. It was set to 5 s for
31P-NMR. All acquisitions were summed over 2K scans and detected using
phase quadrature. A 30-min thermal equilibrium delay was waited before
starting each experiment; temperature was regulated to 60.1C.
DLS
DLS experiments were performed on an ALV/CGS-3 goniometer, coupled
with ALV/LSE-5003 electronics. Hydrodynamic radii were calculated using
ALV-Correlator Software V. 3.0 ﬁtting routines. Hardware and software are
both from ALV-GmbH (Langen, Germany). All DLS experiments were
performed at room temperature (;23C), and samples used were the same as
those used for 2H-NMR, except they were diluted 100 times to be in the
elastic collision range.
TEM
To prepare the TEM samples, 5 mL of an aqueous solution of the different
preparations was deposited on a carbon-coated copper grid, which was
rendered hydrophilic by UV/ozone treatment. Excess lipid solution was
gently removed using absorbent paper. Samples were then negatively stained
with a 2% uranyl acetate solution. TEM images were recorded using a CM
120 Philips Cryo transmission electron microscope operating at 120 kV and
equipped with a USC1000 SSCCD 2k 3 2k Gatan camera.
FIGURE 1 SF primary structure from Peypoux et al. (9). Alkyl chain in posi-
tion 8 and amino acids at positions 2, 4, and7 are variable dependingon isoforms.
Structure for the this study: 1Glu(L)Leu(L)Leu(D)Val(L)Asp(L)Leu(D)Leu(L)7-
isoC14, MW 1036.34.
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Cryo-TEM
A 5-mL sample was deposited onto a holey carbon-coated copper grid. The
excess was blotted with a ﬁlter paper. Unstained samples were frozen into
liquid ethane, and the grids mounted on a Gatan 626 cryoholder were
transferred into the microscope and kept at a temperature near 175C.
Sample observations were performed with a Tecnai-F20 FEI-transmission
electronmicroscope, operating at 200 kV. Low-dose images were recorded at
a nominal magniﬁcation of 29,0003 with a 2k 3 2k USC1000 slow-scan
CCD camera (Gatan, Pleasanton, CA).
Theoretical background and calculations
2H-NMR has been widely used to provide information about structure and
molecular motions in model membranes (34–36). Phospholipids involved in
ﬂuid-phase biomembranes can generally be described as a smectic-like liquid
crystal and undergo rapid axially symmetrical reorientational motions around
the bilayer normal. Because of this axial motion, structural properties of lipid
chains can be described in terms of orientational order parameters. In par-
ticular, a carbon-deuterium orientational order parameter, SCD, can be used to
relate the observed quadrupolar splitting,Dn; to lipid motions (34–36):
DnðuÞ ¼ 3
2
3AQ3
3cos
2
u 1
2
3 SCD; (1)
where AQ ¼ e2qQ=h is the static deuterium quadrupolar coupling constant
(167 kHz for C-2H bonds (37)). u is the angle between the bilayer normal and
the magnetic ﬁeld. SCD is a time average over the molecular motions that are
fast on the NMR time scale (i.e., compared with Dn). The carbon deuterium
bond order parameter of the ith aliphatic chain segment is written as:
S
i
CD ¼
1
2
3 Æ3cos2bi  1æ; (2)
where bi is the angle between the Ci-
2H bond and the motional axis of
symmetry (bilayer normal). Equations 1 and 2 may be applied to every 2H
nuclei in the molecule. Because multilamellar vesicles do not orient in the
magnetic ﬁeld, one generally observes a powder spectrum representative of
all angle distributions: all u -values are possible (generally 0 to 360). When
using perdeuterated chains, as in this work, one obtains a superposition of
powder patterns originating from individual Ci-
2H bonds (i ¼ 2–14). To
gather information about minute chain dynamics (i.e., get individual SiCD),
powder spectra are processed using the ‘‘de-Pake-ing’’ procedure (imple-
mented by Bloom and colleagues (38,39)) to get rid of the u angle
distribution. By doing so, one obtains an oriented-like spectrum (choosing
udepak ¼ 90 for instance) and SiCD can directly be extracted from DniQ:
Dn
iðudepakÞ ¼ DniQ ¼
3
4
AQ3 S
i
CD: (3)
SiCD calculations presented in this article were performed using a PYREX/
PYTHON program (S. Buchoux, unpublished material) based on the Sternin
algorithm (39). Unfortunately, in dealing with experimental spectra, de-
termination of DniQ may be difﬁcult because of low S/N or nonaxially
symmetric spectra. A more global estimate of entire chain ordering may be
obtained from spectral moments (34,40) such as the ﬁrst moment M1:
ÆSCDæchain ¼
ﬃﬃﬃ
3
p
pAQ
M1: (4)
Angular brackets were used to represent the average over all labeled
positions. The ﬁrst moment is deﬁned as:
M1 ¼ 4p
3
ﬃﬃﬃ
3
p ÆDnQæ ¼
RN
N vf ðvÞdvRN
N f ðvÞdv
: (5)
Where v ¼ 0 corresponds to the isotropic frequency. First moments were
calculated using a Python homemade routine to which Bruker NMR data
were exported using a proper subroutine (S. Buchoux, unpublishedmaterial).
To avoid zero values for spectra symmetrical relative to the origin, a sign
reversal was used for negative frequencies.
RESULTS
Deuterium and phosphorus solid-state NMR experiments
were performed as a function of temperature on several lipid
mixtures: DMPC-2H27 liposomes, DMPG-
2H27/SM (1/1)
liposomes, DMPC-2H27/DMPG (1/1) liposomes, and
DMPC-2H27/DMPS (1/1) liposomes. Each system was ana-
lyzed with and without incorporated SF (Ri of 25, 30, 50,
100, and 200). DLS and TEM experiments were performed
only on systems of interest characterized by NMR.
2H NMR spectroscopy
Fig. 2 shows 2H-NMR spectra of the DMPC-2H27 system
with and without SF at three characteristic temperatures
(18C, 21C, and 39C) within the temperature range in-
vestigated (18–48C). Acquisition conditions were kept
identical for all experiments. In the case of pure DMPC-2H27
liposomes (Fig. 2, left), we observe the typical behavior of
this well-studied system (34,35,41,42). At 18C and 21C,
DMPC chains are not melted (i.e., thermally activated mo-
tions are not fast enough to induce molecule and chain dis-
order); the spectrum observed is characteristic of a lamellar
gel phase: there is no fast axial rotation of lipid (no C3 axis
symmetry), and chains are essentially fully extended with an
;30 tilt (43). A very small isotropic line caused by either
FIGURE 2 SF effect on DMPC-2H27 MLV (20 mg in 100 mL).
2H-NMR
spectra are shown at 18C, 21C, and 39C, in the absence of SF (left) and
with SF incorporated (Ri ¼ 25, right). Number of acquisitions ¼ 2k, 50-Hz
Lorentzian ﬁltering.
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residual natural abundance water or by very small vesicles
occurring during the preparation is observed; it can be ne-
glected because of its weak area (,1%). The spectrum ob-
served at 39C is characteristic of a lamellar ﬂuid phase:
lipids undergo fast axially symmetric motions (molecule long
axis rotation and wobbling, chain rotation, chain isomeriza-
tion), which result in liquid-like chain disordering. The
temperature transition between gel and ﬂuid phase occurs
between 21C and 24C, which agrees with the literature: for
DMPC, the phase transition is 23.5C (44) (here it is slightly
lower because chains are perdeuterated (28)). In the presence
of SF (Ri ¼ 25) (Fig. 2, right), no characteristic changes in
spectrum shape occur at 18C. The effect is much more
visible at 21C because the gel phase spectrum evolves to-
ward a ﬂuid phase with SF addition. Very little change is
observed at 39C: the same spectrum width but with a small
line broadening. First moment calculations (not shown) also
reveal that there are no large changes in DMPC membrane
dynamics in the presence of SF: M1 is high at low tempera-
tures (;100 kHz at 18C) and is lower at high temperatures
(;40 kHz at 39C). From the temperature variation of M1
(not shown) one can determine a gel-to-ﬂuid phase transition
temperature of 22 6 1C in the absence of SF and one of
20 6 1C in its presence.
Fig. 3 (four top spectra) shows 2H-NMR of DMPG-2H27/
SM system without (left) and with (right) SF at two tem-
peratures (18C and 39C) within the temperature range in-
vestigated (18–48C). For the DMPG-2H27/SM only system,
we observe a gel phase spectrum at 18C and 39C that is
related to the well-known effect of SM as a promoter of in-
crease in the transition temperature between gel phase and
ﬂuid phase (29). Indeed, transition begins to be observed at
48C, which is twice as high as for the DMPG-only system
(44) (spectrum not shown). Negligible isotropic lines are also
observed independent of temperature. When SF is added to
the system (Ri ¼ 50), we observe a complete conversion of
spectra into isotropic lines at both temperatures. The SF ef-
fect on DMPG-2H27/SM system is remarkable because the
lamellar phase spectrum has completely vanished. The four
bottom spectra of Fig. 3 report on 2H-NMR of DMPC-2H27/
DMPG system without (left) and with (right) SF at 18C and
39C within the temperature range investigated (18–48C).
For the DMPC-2H27/DMPG system, we observe a gel-phase
spectrum at 18C but a ﬂuid-phase spectrum at 39C. Again,
negligible isotropic lines are observed at low and high tem-
peratures. When SF is added to the system, a pure isotropic
spectrum is observed at 18C, as for the DMPG/SM mem-
brane. Interestingly, a small fraction of powder pattern re-
mains visible at 39C, the isotropic line nonetheless being
dominant (;85% of the total spectrum area). Fig. 4 shows 2H
NMR spectra of DMPC-2H27/DMPS system without (left)
and with (right) SF at two typical temperatures (18C and
39C) within the temperature range investigated (18–48C)
and at two different pHs (pH ¼ 4.5, bottom, and 7.5, top).
Acquisition conditions were kept identical for all experi-
ments. Without SF (left), spectra observed are quite similar at
pH ¼ 4.5 and at pH ¼ 7.5: spectra observed at 18C are
characteristic of a gel phase, whereas at 39C they are char-
acteristic of a ﬂuid phase. Negligible isotropic lines are also
observed. When SF is added to the system (right), spectra
showmarked differences: at pH¼ 4.5, lamellar phase spectra
are always observed (at both 18C and 39C), whereas at
pH ¼ 7.5, an isotropic spectrum is detected independent of
temperature. More detail on the pH ¼ 4.5 system may be
obtained by calculating the ﬁrst spectral moment, M1, of
DMPC-2H27 lipid chains (Fig. 5). Without SF, a phase
transition between gel and ﬂuid phases is clearly visible be-
cause of the marked step in theM1 proﬁle on going from low
temperatures (highM1 values (;120 kHz), ordered chains) to
high temperatures (lower M1 values (;40 kHz), disordered
chains). In the presence of SF, M1 is lowered (;100 kHz) at
low temperatures and is increased (;50 kHz) at high tem-
peratures; as a consequence, the phase transition is less vis-
ible. The SCD scale on the right-hand side y axis reﬂects the
M1 behavior on a scale between 1 (full order, rigid lipids and
chains) and 0 (full disorder, as in liquids). The Fig. 5 insert
shows the so-called ‘‘order parameter proﬁle,’’ obtained
from DMPC-2H27 ‘‘de-Paked’’ spectra in DMPC/DMPS at
34C, in the presence and absence of SF. It is clearly seen that
DMPC-2H27 chain order is much higher when SF is present in
FIGURE 3 SF effect on DMPG-2H27/SM (1:1 molar ratio) and
DMPC-2H27/DMPG (1:1 molar ratio) systems (20 mg total lipids in 100
mL). 2H-NMR spectra are shown at 18C and 39C, in the absence (left) and
in the presence of SF (right, Ri ¼ 50). NMR conditions as in Fig. 2.
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the system. This is especially true for ‘‘plateau’’ positions
(carbons 2 to 8) and down to position 11. Toward the chain
end (positions 12 to 14), the effect is less marked or absent
(methyl terminal).
31P NMR Spectroscopy
The effect of lower doses of SF on negatively charged
membrane systems was performed on DMPC/DMPG using
31P NMR spectroscopy because it does not require labeled
materials. Fig. 6 shows the effect of increasing doses of SF
(lipid/peptide ratios of 200, 100, and 50) at 39C and 18C. In
the absence of peptide, one observes the classical axially
symmetric spectra at both temperatures. This is at variance to
what is observed with deuterium NMR because of the still
rotating phosphate headgroup, even in the gel phase. Axially
asymmetric spectra characteristic of frozen headgroup mo-
tions are observed only at very low temperatures (35,45).
Gel- and ﬂuid-phase spectra nonetheless show very distin-
guishable shapes because of the frequency increase of mo-
lecular and intramolecular motions above the phase transition.
Because the chemical shift anisotropies of each of the lipid
headgroups (PC and PG) are about the same, and only one
axially symmetric powder spectrum is observed. Very weak
and negligible isotropic lines are detected and may be assigned
to the formation of a very small amount (,1%) of very small
vesicles. In the presence of SF, a single isotropic line centered
close to 0 ppm is detected, and the more SF the greater is the
line. At Ri ¼ 50, the powder pattern characteristic of mi-
crometer-size multilayered vesicles has almost completely
disappeared, as was seen with deuterium NMR (vide supra).
The line appears independent of the temperature and, although
weak, for very low proportions of peptide.
DLS experiments
DLS experiments were performed on DMPC/DMPG and
DMPC/DMPS (at pH ¼ 7.5) to measure the size of the iso-
tropic objects detected with NMR. Fig. 7 shows the effect of
FIGURE 4 SF effect on DMPC-2H27/DMPS (1:1 molar ratio) system at
pH 7.5 (top) and pH 4.5 (bottom), (20 mg total lipids in 100 mL). 2H-NMR
spectra are shown at 18C and 39C, in the absence (left) and in the presence
of SF (right, Ri ¼ 50). NMR conditions as in Fig. 2.
FIGURE 5 Temperature dependence of M1 calculated for DMPC-
2H27/
DMPS (1:1 molar ratio) spectra at pH 4.5 without SF (squares) and with SF
(Ri ¼ 50, triangles). (Inner graph) SCD proﬁle calculated for de-Paked
spectra (see text) at T ¼ 34C. Labeled carbon positions were assigned
according to the literature. Experimental error is in symbol size.
FIGURE 6 SF effect on DMPC/DMPG (1:1 molar ratio) systems (20 mg
total lipids in 100 mL). 31P-NMR spectra are shown at 18C and 39C, with
increasing amounts of SF from top to bottom. Number of acquisitions ¼ 1k,
50-Hz Lorentzian ﬁltering.
3844 Buchoux et al.
Biophysical Journal 95(8) 3840–3849
increasing amounts of SF on the hydrodynamic radius, Rh, of
DMPC/DMPG MLV at room temperature (23C). Hetero-
geneous sizes centered on Rh 1000 nm are mostly detected
in the absence of peptide. A small proportion of smaller
objects with Rh  220 nm are also observed. This accounts
well for the small proportion of isotropic lines detected on
top of NMR powder spectra. On addition of SF, Ri ¼ 100
(Fig. 7), the system is almost entirely converted into objects of
Rh  220 nm. A small proportion of smaller sizes are also
detected (Rh  40 nm). With Ri ¼ 50, the population with
Rh  35 nm dominates, with a very narrow distribution (6 2
nm). For Ri¼ 25, even smaller objects are detected, Rh 15
nm, with a 65 nm asymmetric size distribution. Similar ob-
servations are made for DMPC/DMPS at pH ¼ 7.5 (not
shown).
TEM
After the preparation outlined in Materials and Methods,
electron microscopy images were taken on the system
DMPC/DMPG with and without SF (Fig. 8). Control ex-
FIGURE 7 Effect of SF on the hydrodynamic radius of DMPC/DMPG
(1:1 molar ratio) MLV, as monitored by DLS. Lipid/peptide molar ratios are
shown on graphs. Temperature was regulated at 25C.
FIGURE 8 TEM images of SF and of DMPC/DMPG (1:1 molar ratio) with-
out and with lipopeptide, using negative staining (A, B, and C) and cryo-TEM
(D). (A) SFmicelles, bar: 100 nm. (B)MLV in the absence of peptide, bar¼ 200
nm. (C) With SF, Ri ¼ 50, bar: 200 nm. (D) Same as C observed using cryo-
TEM, bar: 25 nm.
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periments were also taken on a pure SF micellar dispersion
Fig. 8 A: micelles of 10–50 nm size are observed because the
dispersion is well above the CMC (a few micromolar).
DMPC/DMPG liposomes were also imaged, and the classical
‘‘onion-like’’ structure of micrometer size was observed
(Fig. 8 B). It is clear that on addition of small amounts (Ri ¼
50, Fig. 8 C) of SF, the morphology and size of the initially
observed micrometer multilamellar vesicles is considerably
modiﬁed: vesicles of;100–200 nm are observed. Additional
Cryo-TEM experiments were performed and established that
virtually all vesicles formed when SF is added are unilamellar
(Fig. 8 D), with a bilayer thickness estimated to be ;5 nm.
External addition of SF as a micellar water solution (6 mM) to
preformed MLV (not shown) leads to the same ﬁnal state as
observed in Fig. 8, where the peptide was codissolved with
lipids and membranes formed after solvent evaporation,
lyophilization, and rehydration (see Materials and Methods).
DISCUSSION
Three major ﬁndings emerge from our NMR, DLS, and TEM
experiments. 1), Very low doses of SF lead to transformation
of large membrane dispersions into small unilamellar vesi-
cles. 2), Part of the mechanism is clearly driven by electro-
static repulsion because it occurs only on negatively charged
systems and independent of the physical state of the lipid. 3),
The SF has a cholesterol-like action on membranes when the
electrostatic interaction is diminished or cancelled. These results
are presented in detail and discussed in the following sections.
Transformation of MLV into SUV
A lipid/SF ratio of 50 (;4 mol % of SF) almost entirely
converts multilamellar vesicles of micrometer size into small
spherical objects of ;70 nm. This is detected by the ap-
pearance of an isotropic line in 2H-NMR spectra: i.e., the
newly formed small objects undergo fast tumbling that av-
erages to zero the large quadrupolar interaction. This has
been observed on several membrane systems: DMPC-2H27/
DMPG, DMPG-2H27/SM, and DMPC-
2H27/DMPS (at pH ¼
7.5). Small objects formation has been conﬁrmed by DLS
because no micrometer-scaled vesicles are observed on SF
addition. Interestingly, a lipid/peptide ratio of 50 appears to
be sufﬁcient to transform almost the entire MLV into a nar-
row population of vesicles. Smaller particles (e.g., mixed
micelles, very small vesicles) are formed on increasing the
amount of SF (diameter of ;30 nm for Ri ¼ 25), whereas
lower doses of SF (Ri ¼ 100 or 200) lead to larger vesicles
(400–500 nm). The observation of a dose-dependent size
transformation is also conﬁrmed using 31P-NMR: only a
small fraction of isotropic line superimposed on a powder
pattern is observed at high Ri. Interestingly, at low and high
doses, the population of vesicles is heterogeneous in size,
whereas it is very narrow at Ri ¼ 50. Additionally, TEM
experiments on negatively stained DMPC/DMPG vesicles
without SF and with Ri ¼ 50 also demonstrate SF-induced
formation of small objects, presumably small unilamellar
vesicles. Complementary cryo-TEM experiments clearly
establish that these small objects are unilamellar vesicles,
with a bilayer thickness of;5 nm. SF-induced multilamellar
vesicles destabilization is quasi-independent of the physical
state of lipids. It indeed happens on the low- and high-tem-
perature phases of DMPC/DMPG or DMPC/DMPS systems
and on DMPG/SM systems that are in a very ordered gel-like
phase at both ambient and 40–50C temperatures. The fact
that lipid chains are in a liquid-disordered or solid ordered
phase appears not to be an important parameter for the in-
teraction. This is in contrast with other lysis-inducing pep-
tides, such as the bee-venom melittin, where small particles
are preferentially formed with rigid chain lipids (46–50).
DLS and electron microscopy conﬁrm that objects of 70-nm
size are thus formed on action of SF on these systems. TEM
clearly demonstrates that with Ri ¼ 50 small unilamellar
vesicles are stabilized. Interestingly, an Ri of 50 appears to be
sufﬁcient to transform almost the entire MLV entirely into a
narrow population of vesicles. Smaller particles are formed
on increasing the amount of SF (diameter of;30 nm for Ri¼
25), whereas lower doses of SF (Ri ¼ 100 or 200) lead to
larger vesicles (400–500 nm). The observation of a dose-
dependent size transformation is also conﬁrmed using
31P-NMR: only a small fraction of isotropic line super-
imposed on a powder pattern is observed at high Ri. Inter-
estingly, at low and high doses, the population of vesicles is
heterogeneous in size, whereas it is very narrow at Ri ¼ 50.
From our results, it is clear that a considerable effect is in-
duced by SF on negatively charged membrane systems of
different lipid nature. Effects of SF on both biological systems
(16,19) and model systems (25–27,51,52) have already been
reported, but the doses applied were much higher. In partic-
ular, recent 2H- and 31P-NMR studies (26,27) performed on
POPC reveal a complete membrane disruption for a lipid/SF
ratio of ;4. This suggests that for high doses, the ‘‘wedge’’
shape of SF may exert a destabilizing effect in the absence of
any electrostatic action. Experiments have been reported on
phosphatidylethanolamine and negatively charged lipids
(DMPG) by calorimetry and x rays. A deep insertion of SF
and bilayer stabilization were observed (52); unfortunately,
the techniques used did not allow detection of small vesicles.
Electrostatic repulsion as the key interaction
It appears rather clear that repulsion between SF negative
charges (Asp and Glu residues) and DMPG headgroup neg-
ative charge lead to formation of SUVs. Interestingly, SUVs
occur with DMPC/DMPS at pH ¼ 7.5 but not at pH ¼ 4.5.
DMPS is indeed an interesting lipid because its headgroup
charge is dependent on pH (44). At pH ¼ 4.5, the carboxylic
acid function of a serine headgroup is protonated, and amino
and phosphate groups are still charged (respectively posi-
tively and negatively); as a consequence, DMPS is then
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zwitterionic, leading to a globally neutral membrane (53). At
pH ¼ 7.5, DMPS is anionic because its carboxylic acid
function is deprotonated. As a consequence DMPC-2H27/
DMPS liposomes are negatively charged. Because SF is also
negatively charged at pH ¼ 7.5, we may also explain the
formation of DMPC-2H27/DMPS SUV by charge repulsions.
In contrast, at pH ¼ 4.5, the PS headgroup is protonated and
globally neutral so the DMPC-2H27/DMPS membrane is
zwitterionic. Although SF may still be negatively charged at
pH ¼ 4.5 (54), no SUV formation is observed at such pH
because there are no longer charge repulsions between SF
and the PS headgroup. The partial protonation of carboxyl
groups would even allow the whole peptide to insert into the
lipid in a way similar to that of cholesterol (vide infra).
SF and lipids dynamics
When the membrane system is not converted into small ob-
jects on SF action, i.e., in the presence of zwitterionic mem-
branes, one observes powder patterns with NMR and
therefore, a minute analysis of membrane dynamics may be
carried out from the deuterium NMR data. Concerning the
DMPC system, no crucial effect is observed when SF is added
to it, except for a broadening and lowering of the gel-to-ﬂuid
phase transition: at 21C the 2H-NMR spectrum observed
with SF is much closer to a ﬂuid phase spectrum, whereas it is
mostly of gel-type for pure DMPC-2H27. Results obtained
with DMPC-2H27/DMPS system at pH 4.5 reveal that SF at
Ri¼ 50 lowers lipid chain order at low temperature and raises
it at high temperature, leading to broadening of the gel-to-
ﬂuid phase transition. Of interest is the fact that the acyl chain
ordering increases in the ﬂuid phase for almost all positions
except for the methyl terminal. This effect is very similar to
what is observed with cholesterol in membranes, except that
cholesterol also orders the chain ends (40,42,43,55,56). We
may account for this behavior by a deep insertion of SF into
the bilayer core. In the presence of rigid chains (gel phase), SF
will prevent close packing of chains and then alter phase
transition phenomena and membrane ordering, whereas on a
ﬂuid phase, the peptide rigid ring may to some extent play the
same role as the fused rings of cholesterol, i.e., increasingVan
der Waals interactions and promoting membrane ordering.
The fact that the chain ends are less ordered suggests none-
theless that SF is less embedded than cholesterol in the bi-
layer. This cholesterol-like behavior, not observed with SF in
pure DMPC-2H27 membrane, may be enhanced by interac-
tions between the SF peptidic backbone and the DMPS serine
headgroup, as proposed in the recent work using molecular
dynamics to study SF/membrane interactions (57).
Proposed mechanism of action
Results presented in this article reveal that application of low
doses of SF on negatively charged membranes promotes
micrometric size membrane destabilization and leads to the
formation of SUVs of a few 10s of nanometers. Additionally,
this behavior is essentially driven by repulsions between
negatively charged acidic residues from SF and negative
charges located on the lipid headgroup (PG and PS at pH
7.5). Lipids dynamics does not seem to be an important issue
concerning SF interactions with membranes because SUV
formation occurs both with gel- and ﬂuid-phase lipids. A
hypothetical model for membrane morphological transfor-
mation (lysis) can be proposed based on these observations
(Fig. 9). The ﬁrst stage would be 1), a penetration of SF into
the lipid bilayer because of a favorable hydrophobic inter-
action between SF and the membrane; 2), charge repulsions
take place between SF negative charges and the lipid head-
group negative charges, which leads to local increase of
membrane curvature; and 3), a complete destabilization of
the planar membrane and formation of resulting SUVs. This
is what is usually called ‘‘direct lysis’’; i.e., while the
chemical integrity of the lipid is preserved, the membrane
morphology is dramatically changed, leading to severe
leakage of the liposome and, by extrapolation to microor-
ganisms, to cell contents. Compared with the well-studied
‘‘carpet’’ and ‘‘barrel’’ models (58,59), our model presented
here does not rely on helix conformation or presence of basic
residues, as reported for many antibacterial peptides. Neither
helical nor b-sheet structure can be adopted by SF because of
its cyclic structure.
The presented mechanism may also apply to membrane
direct lysis induced by other lipopeptides secreted by Bacillus
subtilis. For example, it would be interesting to make sim-
ilar experiments with the iturinic antibiotics (mycosubtilin,
bacillomycins L and D), which are lipopeptides like SF but
differ by their chiral sequence of L/D enantiomer amino acids
(LDDLLDL instead of LLDLLDL in SF) and by the nature of
the cycling fatty acid (b-amino fatty acid instead of b-hydroxy
fatty acid in SF).
FIGURE 9 Artist view illustrating the ‘‘wedge-repulsion’’ model: SF
molecules penetrate into the hydrophobic core of membranes because of
favorable hydrophobic forces, and an electrostatic repulsion occurs between
negative charges of peptidic amino acids Glu/Asp and negatively charged
lipid headgroups. This promotes an increase in local membrane curvature,
which destabilizes MLV (A) to form SUVs (B).
Surfactin-Induced SUV Formation 3847
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